Nyxoah SA
NYXH · XNASCIK 1857190fmd_1ZPFKW29F1P31EHMQJAJ1W0SAWManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2019 to Dec 31, 2025, 13 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Cost of revenue | – | 0 | 0 | 1 | 2 | 2 | 4 |
| Gross profit | – | 0 | 1 | 2 | 3 | 3 | 6 |
| Research and development | – | 2 | 12 | 16 | 27 | 34 | 43 |
| Selling, general and administrative | – | 9 | 15 | 19 | 22 | 28 | 48 |
| Operating income | – | (11) | (26) | (32) | (45) | (59) | (83) |
| Interest expense | – | 1 | 2 | 4 | 4 | 5 | 12 |
| Income before taxes | (8) | (12) | (25) | (30) | (45) | (56) | (89) |
| Income tax expense | – | 0 | 3 | 1 | (1) | 3 | 1 |
| Net income from continuing operations | – | (12) | (28) | (31) | (43) | (59) | (90) |
| Net income | – | (12) | (28) | (31) | (43) | (59) | (90) |
| Net income to common shareholders | – | – | – | (31) | (43) | (59) | (90) |